Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thyroid Neoplasms × sacituzumab govitecan × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Metastatic Solid Tumors 1 Glioblastoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Hepatocellular 1

Interventions

vandetanib 7 lenvatinib 5 cabozantinib 4 Sunitinib 4 Sorafenib 4 AZD 6244 3 selpercatinib 2 durvalumab 2 alectinib 2 Triiodothyronine 2 Thyroxine 2 Paclitaxel 2 Iodine-131 2 Everolimus 2 Bortezomib 2 Axitinib 2 tremelimumab 1 tipifarnib 1 temsirolimus 1 tanespimycin 1 sapanisertib 1 regorafenib 1 pralsetinib 1 ponatinib 1 perflutren 1 pazopanib 1 pasireotide 1 methyl N-acetylsibirosaminide 1 gallium 68 PSMA-11 1 fosbretabulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡